DYRK2 and lung adenocarcinoma: And yet others have noted amplification and overexpression of DYRK2 in esophageal and lung adenocarcinoma, as well as gastric stromal tumor, suggesting that DYRK2 can behave as a potential oncogene [17–19], although the protein levels of the gene were not examined.